Evaluation of vancomycin and daptomycin MIC trends for methicillinresistant Staphylococcus aureus blood isolates over an 11 year period

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 11, 2013, Pages 2689-2691

  Sancak, Banu ^a   Yagci, Server ^b   Mirza, Hasan Cenk ^c   Hascelik, Gulsen ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c Ermenek Government Hospital   (Turkey)

Author keywords

MIC creep; Mrsa; Susceptibility

Indexed keywords

DAPTOMYCIN; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; BROTH DILUTION; EPSILOMETER TEST; IN VITRO STUDY; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION;

MIC CREEP; MRSA; SUSCEPTIBILITY;

ANTI-BACTERIAL AGENTS; DAPTOMYCIN; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 84886236853     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt247     Document Type: Letter

References (10)

1. Dhand A, Sakoulas G. Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates ('the MIC creep'): implications for therapy. F1000 Med Rep 2012; 4: 4.
2. Howden BP, Davies JK, Johnson PD et al. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycinintermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev 2010; 23: 99-139.
3. Soriano A, Marco F, Martinez JA et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2008; 46: 193-200.
4. van Hal SJ, Barbagiannakos T, Jones M et al. Methicillin-resistant Staphylococcus aureus vancomycin susceptibility testing: methodology correlations, temporal trends and clonal patterns. J Antimicrob Chemother 2011; 66: 2284-7.
5. Appleman MD, Citron DM. Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years. Diagn Microbiol Infect Dis 2010; 66: 441-4.
6. Sader HS, Becker HK, Moet GJ et al. Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/ mL isolated in the United States and European hospitals (2006-2008). Diagn Microbiol Infect Dis 2010; 66: 329-31.
7. Sader HS, Jones RN. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008). Diagn Microbiol Infect Dis 2009; 65: 158-62.
8. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically- Eighth Edition: Approved Standard M07-A8. CLSI,Wayne, PA, USA, 2009.
9. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement M100-S19. CLSI,Wayne, PA, USA, 2009.
10. Carroll KC, Glanz BD, Borek AP et al. Evaluation of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of Enterobacteriaceae. J Clin Microbiol 2006; 44: 3506-9.